<?xml version='1.0' encoding='utf-8'?>
<document id="23229074"><sentence text="Vilazodone hydrochloride, a combined SSRI and 5-HT1A receptor agonist for major depressive disorder."><entity charOffset="0-24" id="DDI-PubMed.23229074.s1.e0" text="Vilazodone hydrochloride" /></sentence><sentence text="Vilazodone (VIIBRYD, Trovis Pharmaceuticals; New Haven, Connecticut, also known as 659746, EMD68843, SB-659746-A) is a newly introduced antidepressant that has taken approximately a decade from its discovery to approval by the Food and Drug Administration"><entity charOffset="0-10" id="DDI-PubMed.23229074.s2.e0" text="Vilazodone" /><entity charOffset="12-19" id="DDI-PubMed.23229074.s2.e1" text="VIIBRYD" /><entity charOffset="101-112" id="DDI-PubMed.23229074.s2.e2" text="SB-659746-A" /><pair ddi="false" e1="DDI-PubMed.23229074.s2.e0" e2="DDI-PubMed.23229074.s2.e0" /><pair ddi="false" e1="DDI-PubMed.23229074.s2.e0" e2="DDI-PubMed.23229074.s2.e1" /><pair ddi="false" e1="DDI-PubMed.23229074.s2.e0" e2="DDI-PubMed.23229074.s2.e2" /><pair ddi="false" e1="DDI-PubMed.23229074.s2.e1" e2="DDI-PubMed.23229074.s2.e1" /><pair ddi="false" e1="DDI-PubMed.23229074.s2.e1" e2="DDI-PubMed.23229074.s2.e2" /></sentence><sentence text=" This paper will review the chemistry, pharmacodynamics, pharmacokinetics, clinical efficacy, tolerability, drug-drug interaction potential, dosing, and administration of this agent" /><sentence text="" /><sentence text="Medline/PubMed/IPA/EMBASE databases were searched using the terms &quot;vilazodone,&quot; &quot;659746,&quot; &quot;EMD68843,&quot; and &quot;SB-659746-A" /><sentence text="&quot; All English-language papers from 1985 to April 2012 were reviewed for relevance" /><sentence text=" Bibliographies of all papers were reviewed to identify further papers" /><sentence text="" /><sentence text="All English-language papers from 1985 to present appearing in these searches were reviewed for relevance to this paper" /><sentence text=" In addition, their bibliographies were reviewed to identify any papers not identified in the searches" /><sentence text=" Data are expressed as mean or mean Â± standard deviation, unless otherwise noted" /><sentence text="" /><sentence text="Vilazodone is the first combined selective serotonin reuptake inhibitor (SSRI)/5-HT1A receptor agonist antidepressant"><entity charOffset="0-10" id="DDI-PubMed.23229074.s13.e0" text="Vilazodone" /><entity charOffset="43-52" id="DDI-PubMed.23229074.s13.e1" text="serotonin" /><pair ddi="false" e1="DDI-PubMed.23229074.s13.e0" e2="DDI-PubMed.23229074.s13.e0" /><pair ddi="false" e1="DDI-PubMed.23229074.s13.e0" e2="DDI-PubMed.23229074.s13.e1" /></sentence><sentence text=" Vilazodone must be administered with food to optimize bioavailability"><entity charOffset="1-11" id="DDI-PubMed.23229074.s14.e0" text="Vilazodone" /></sentence><sentence text=" The primary route of elimination is metabolism followed by excretion of metabolites" /><sentence text=" Advancing age and renal and hepatic impairment do not alter its disposition" /><sentence text=" Early phase II clinical trials were unable to demonstrate antidepressant efficacy" /><sentence text=" However, later phase III trials using 40 mg daily doses were able to demonstrate superior efficacy compared with placebo treatment" /><sentence text=" Adverse events, warnings, and precautions mirror those of other SSRIs" /><sentence text="" /><sentence text="Although there are theoretical reasons why 5-HT1A agonism may be a desirable additional property in antidepressants, there is no evidence to date that vilazodone has any advantage over existing post-tricyclic antidepressants"><entity charOffset="151-161" id="DDI-PubMed.23229074.s21.e0" text="vilazodone" /></sentence><sentence text=" It has a narrow therapeutic dosing range whose upper boundary is close to that producing intolerable gastrointestinal and central nervous system adverse events" /><sentence text=" Further research will clarify and refine the role of vilazodone in the management of psychiatric disorders"><entity charOffset="54-64" id="DDI-PubMed.23229074.s23.e0" text="vilazodone" /></sentence><sentence text="" /></document>